ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications

September 4, 2009

In Brief: Owens New President Of AACI, Yates President Elect; UNC Gains Comprehensive Center Status

June 29, 1990

EMEND Improved Emesis In Men And Women, Trials Find

December 26, 2003

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

November 16, 1979

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

February 9, 1990

NCI Shakeup Possibilities Grow; Marc Lippman To Head Lombardi Center; DCT Could Lose CTEP

March 11, 1988